Franklin Salisbury
Fundador en Aim-Hi Accelerator Fund, Inc. .
Cargos activos de Franklin Salisbury
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Aim-Hi Accelerator Fund, Inc.
Aim-Hi Accelerator Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Aim-Hi Accelerator Fund, Inc. is a non-profit company that was born out of the National Foundation for Cancer Research (NFCR). The company is based in Rockville, MD. The company aims to bridge the gap between innovative, early-stage cancer research and successful development of high-impact oncology products. Aim-Hi is a new paradigm to fund translational research designed to focus on startups that have commercial potential at cancer therapeutic discovery. The company was founded by Sujuan Ba, Charlie Weatherspoon, Franklin Cary Salisbury. Sujuan Ba has been the CEO since incorporation. | Director/Miembro de la Junta | 01/01/2019 | - |
Fundador | 01/01/2019 | - |
Historial de carrera de Franklin Salisbury
Antiguos cargos conocidos de Franklin Salisbury.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
National Foundation for Cancer Research
National Foundation for Cancer Research Miscellaneous Commercial ServicesCommercial Services The National Foundation for Cancer Research is a non-profit organization that provides funding to scientists for cancer research. The non-profit company is based in Bethesda, MD. The company's mission is to support life-saving discoveries for cancer patients. | Director/Miembro de la Junta | 08/02/2019 | - |
Director Ejecutivo | - | 08/02/2019 | |
Presidente | 01/01/1998 | - | |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Director/Miembro de la Junta | 02/06/2014 | - |
Independent Dir/Board Member | 29/04/2015 | - |
Formación de Franklin Salisbury.
Yale University | Undergraduate Degree |
The University of Chicago | Graduate Degree |
Yale Divinity School | Graduate Degree |
University of Georgia School of Law | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Director/Board Member | 3 |
Graduate Degree | 3 |
Independent Dir/Board Member | 1 |
Sectorial
Consumer Services | 5 |
Commercial Services | 3 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
National Foundation for Cancer Research
National Foundation for Cancer Research Miscellaneous Commercial ServicesCommercial Services The National Foundation for Cancer Research is a non-profit organization that provides funding to scientists for cancer research. The non-profit company is based in Bethesda, MD. The company's mission is to support life-saving discoveries for cancer patients. | Commercial Services |
Aim-Hi Accelerator Fund, Inc.
Aim-Hi Accelerator Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Aim-Hi Accelerator Fund, Inc. is a non-profit company that was born out of the National Foundation for Cancer Research (NFCR). The company is based in Rockville, MD. The company aims to bridge the gap between innovative, early-stage cancer research and successful development of high-impact oncology products. Aim-Hi is a new paradigm to fund translational research designed to focus on startups that have commercial potential at cancer therapeutic discovery. The company was founded by Sujuan Ba, Charlie Weatherspoon, Franklin Cary Salisbury. Sujuan Ba has been the CEO since incorporation. | Commercial Services |
- Bolsa de valores
- Insiders
- Franklin Salisbury
- Experiencia